HEMISPHERIAN AS
925333409ActiveDeveloping novel small molecule drugs targeting TET2 for aggressive cancers.
Oversigt
- 5
- Medarbejdere
- 269t NOK
- Omsætning
- 2020
- Grundlagt
Nøglebeslutningstagere
Roger Stupp
Chair of the Clinical Advisory Board
Michael Lim
Member of the Clinical Advisory Board
Monika Hegi
Member of the Clinical Advisory Board
Einar O. Vik-Mo
Member of the Clinical Advisory Board
+2 flere kontakter i Funnelfeedr
Beskrivelse
Hemispherian is an innovative preclinical pharmaceutical company dedicated to redefining targeted cancer therapeutics. The core focus is developing a novel class of small molecule drugs that specifically target the TET2 enzyme. These compounds are designed as targeted therapies for particularly aggr...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- Aksjeselskap
- Momsnummer
- Ukendt
Beslutningstagere
6 kontakter i FunnelfeedrRoger Stupp
Chair of the Clinical Advisory Board
Michael Lim
Member of the Clinical Advisory Board
Monika Hegi
Member of the Clinical Advisory Board
Einar O. Vik-Mo
Member of the Clinical Advisory Board
Isabelle M. Germano
Member of the Clinical Advisory Board
Andre kontakter
Josipa Matic
Medicinal Chemist (H2020 Funded)
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
One-carbon Therapeutics AB
Clinical-stage biotech pioneering novel anti-cancer therapies targeting metabolism.
ONCOSYNE AS
Developing cancer treatments using patient-derived 3D tumoroid models.
Double Bond Pharmaceutical AB
5–9 medarbejdereDeveloping advanced drug delivery systems for targeted cancer and pneumonia treatment.
OSLO SCIENCE HUB AS
Accelerating cancer treatment development through collaboration and innovation.
EXACT THERAPEUTICS AS
13 medarbejdereClinical-stage company developing ultrasound-mediated targeted therapy enhancement.
Udforsk mere
Spørgsmål om HEMISPHERIAN AS
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo